Headache in a young woman: Leptomeningeal metastasis as the first presentation of underlying breast malignancy

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Mohan, Poornima ^a   Antonelou, Marilina ^a   Dadzie, Ophelia ^a   Dubrey, Simon ^a  

^a HILLINGDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CA 125 ANTIGEN; DEXAMETHASONE; FLUORODEOXYGLUCOSE; FLUOROPYRIMIDINE; PLATINUM; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; DIZZINESS; FACIAL NERVE PARALYSIS; FEMALE; FOCAL EPILEPSY; FOLLOW UP; HEADACHE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MENINGEAL METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ADENOCARCINOMA; BREAST TUMOR; COMPLICATION; EPILEPSIES, PARTIAL; FACIAL PARALYSIS; FATALITY; MAMMOGRAPHY; MENINGEAL NEOPLASMS; PALLIATIVE THERAPY; PATHOLOGY; PROCEDURES; SECONDARY; SKULL IRRADIATION;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CRANIAL IRRADIATION; EPILEPSIES, PARTIAL; FACIAL PARALYSIS; FATAL OUTCOME; FEMALE; HEADACHE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MENINGEAL NEOPLASMS; PALLIATIVE CARE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84929631107     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-207643     Document Type: Article

References (27)

1. Ahn S, Lim KS. Three cases of neoplastic meningitis initially diagnosed with infectious meningitis in emergency department. Case Rep Emerg Med 2013;2013:561475.
2. Mirakhur B, Mckenna M. Recurrent herpes simplex type 2 virus (Mollaret meningitis). J Am Board Fam Med 2004;17:305-7.
3. Rudnicka H, Niwinska A, Murawska M. Breast cancer leptomeningeal metastasis- the role of multimodality treatment. J Neuro Oncol 2007;84:57-62.
4. Pentheroudakis G, Pavlidis N. Management of leptomeningeal malignancy. Expert Opin Pharmacother 2005;6:1115-25.
5. Kim L, Glantz MJ. Neoplastic meningitis. Curr Treat Options Oncol 2001;2:517-27.
6. Tailibert S, Laigle-Donadey F, Chodkiewicz C, et al. Leptomeningeal metastases form solid malignancy: A review. J Neurol 2005;75:85-99.
7. Chamberlain MC. Leptomeningeal metastasis. Semin Neurol 2010;30:236-44.
8. Altunag K, Bondy ML, Mirza MQ, et al. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 2007;110:2640-7.
9. Kim HJ, Im SA, Keam B, et al. Clinical outcome of central nervous system metastases from breast cancer: Differences in survival depending on systemic treatment. J Neuro Oncol 2012;106:3030313.
10. Posner JB. Neurologic complications of cancer. Philadelphia, PA: F A Davis Company, 1995:143-68.
11. Choudary S, Chamberain M. Leptomeningeal metastases: Current concepts and management guidelines. J Natl Compr Canc Netw 2005;3:693-703.
12. Norum LF, Eriskstein B, Nustad K. Elevated CA125 in breast cancer-a sign of advanced disease. Tumour Biol 2001;22:223-8.
13. Leonard GD, Low JA, Berman AW, et al. CA125 elevation in breast cancer: A case report and review of the literature. Breast J 2004;10:146-9.
14. Yerushalmil R, Tyldesley S, Kenneckel H, et al. Tumour markers in metastatic breast cancer subtypes: Frequency of elevation and correlation with outcome. Ann Oncol 2012;23:338-45.
15. Kosmas C, Tsavaris NB, Tsakonas G, et al. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer. Med Sci Monit 2005;11:CR398-401.
16. Corsini E, Bernadi G, Gaviani P, et al. Intrathecal synthesis of tumour markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid tumours. Clin Chem Lab Med 2009;47:874-9.
17. Edlow JA, Panagos PD, Godwin SA, et al, The American College of Emergency Physicians Clinical Policies Subcommittee. Clinical policy: Critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache. Ann Emerg Med 2008;52:407-36.
18. Headaches: Diagnosis and management of headaches in young people and adults. National Institute for health and care excellence. Guideline-Cg150. Sept 2012. https://www..org.uk/guidance/cg150/chapter/1-guidance
19. Le Rhun E, Tailibert S, Chamberlain MC. Carcinomatous meningitis: Leptomeningeal metastases in solid tumours. Surg Neurol Int 2013;4:S265-88. http://dx.doi.org/10. 4103/2152-7806.111304
20. Sze G, Soletsky S, Bronen R, et al. MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. Am J Neuroradiol 1989;10:965-75.
21. Singh SK, Leeds NE, Ginsberg LE. Metastases: MR imaging of leptomeningeal metastases: Comparison of three sequences. Am J Neuroradiol 2002;23:817-21.
22. Scott BJ, Kesari S. Leptomeningel metastases in breast cancer. Am J Cancer Res 2013;3:117-26.
23. McNally ME, Carson W. Occult breast malignancy presenting as lepatomeningeal carcinomatosis. World J Oncol 2012;3:73-7.
24. Jo JC, Kang MJ, Kim JE, et al. Clinical features and outcomes of leptomeningeal metastasis in patients with breast cancer: A single center experience. Cancer Chemother Pharmacol 2013;72:201-7.
25. Chamberlain M, Soffietti R, Raizer J, et al. Leptomeningeal metastasis: A response assessment in neuro-oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro Oncol 2014;16:1176-85.
26. Schneck MJ, Berman SA. Leptomeningeal carcinomatosis treatment and management. Medscape: Drugs, diseases and procedures. 2014. http://emedicine. medscape.com/article/1156338-treatment (accessed 17 Dec 2014
27. Kejleh TA, Clamon G. Advances in the systemic treatment of leptomeningeal cancer. Clin Adv Hematol Oncol 2012;10:166-70.